Northern Trust’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,327,363
| Closed | -$52.2M | – | 4604 |
|
|
2023
Q2 | $52.2M | Buy |
1,327,363
+24,641
| +2% | +$870K | 0.01% | 944 |
|
|
2023
Q1 | $31.7M | Buy |
1,302,722
+38,920
| +3% | +$852K | 0.01% | 1246 |
|
|
2022
Q4 | $27.1M | Buy |
1,263,802
+163,795
| +15% | +$3.5M | 0.01% | 1345 |
|
|
2022
Q3 | $19.7M | Buy |
1,100,007
+14,964
| +1% | +$196K | ﹤0.01% | 1470 |
|
|
2022
Q2 | $10.4M | Buy |
1,085,043
+29,926
| +3% | +$376K | ﹤0.01% | 2000 |
|
|
2022
Q1 | $17.8M | Sell |
1,055,117
-42,484
| -4% | -$628K | ﹤0.01% | 1762 |
|
|
2021
Q4 | $18.4M | Buy |
1,097,601
+124,791
| +13% | +$2.05M | ﹤0.01% | 1826 |
|
|
2021
Q3 | $15.8M | Buy |
972,810
+109,918
| +13% | +$1.2M | ﹤0.01% | 1956 |
|
|
2021
Q2 | $5.45M | Buy |
862,892
+47,200
| +6% | +$304K | ﹤0.01% | 2790 |
|
|
2021
Q1 | $5.04M | Sell |
815,692
-50,816
| -6% | -$308K | ﹤0.01% | 2736 |
|
|
2020
Q4 | $5.99M | Sell |
866,508
-2,016
| -0.2% | -$12.9K | ﹤0.01% | 2570 |
|
|
2020
Q3 | $4.9M | Buy |
868,524
+361,965
| +71% | +$1.73M | ﹤0.01% | 2539 |
|
|
2020
Q2 | $2.58M | Buy |
506,559
+434,230
| +600% | +$1.81M | ﹤0.01% | 2895 |
|
|
2020
Q1 | $249K | Buy |
72,329
+7,481
| +12% | +$43.7K | ﹤0.01% | 3633 |
|
|
2019
Q4 | $556K | Sell |
64,848
-22,181
| -25% | -$79.2K | ﹤0.01% | 3533 |
|
|
2019
Q3 | $97K | Hold |
87,029
| – | – | ﹤0.01% | 3933 |
|
|
2019
Q2 | $114K | Buy |
87,029
+93
| +0.1% | +$128 | ﹤0.01% | 3946 |
|
|
2019
Q1 | $123K | Sell |
86,936
-93
| -0.1% | -$130 | ﹤0.01% | 3878 |
|
|
2018
Q4 | $104K | Buy |
87,029
+12,594
| +17% | +$24.4K | ﹤0.01% | 3912 |
|
|
2018
Q3 | $176K | Sell |
74,435
-17
| -0% | -$42 | ﹤0.01% | 3892 |
|
|
2018
Q2 | $203K | Hold |
74,452
| – | – | ﹤0.01% | 3849 |
|
|
2018
Q1 | $204K | Buy |
74,452
+21,330
| +40% | +$61.8K | ﹤0.01% | 3830 |
|
|
2017
Q4 | $166K | Hold |
53,122
| – | – | ﹤0.01% | 3862 |
|
|
2017
Q3 | $150K | Sell |
53,122
-12,982
| -20% | -$35.1K | ﹤0.01% | 3861 |
|
|
2017
Q2 | $169K | Sell |
66,104
-283,635
| -81% | -$773K | ﹤0.01% | 3846 |
|
|
2017
Q1 | $1.28M | Buy |
349,739
+9,444
| +3% | +$39.9K | ﹤0.01% | 3263 |
|
|
2016
Q4 | $1.64M | Buy |
340,295
+1,519
| +0.4% | +$45.1K | ﹤0.01% | 3191 |
|
|
2016
Q3 | $15.6M | Buy |
338,776
+2,341
| +0.7% | +$132K | ﹤0.01% | 1766 |
|
|
2016
Q2 | $17.2M | Buy |
336,435
+63,224
| +23% | +$3.14M | 0.01% | 1643 |
|
|
2016
Q1 | $11.5M | Buy |
273,211
+6,796
| +3% | +$346K | ﹤0.01% | 1870 |
|
|
2015
Q4 | $20.9M | Buy |
266,415
+8,377
| +3% | +$484K | 0.01% | 1479 |
|
|
2015
Q3 | $10.5M | Buy |
258,038
+103,019
| +66% | +$5.46M | ﹤0.01% | 1971 |
|
|
2015
Q2 | $8.07M | Buy |
155,019
+10,708
| +7% | +$533K | ﹤0.01% | 2205 |
|
|
2015
Q1 | $6.71M | Buy |
144,311
+1,961
| +1% | +$102K | ﹤0.01% | 2323 |
|
|
2014
Q4 | $6.39M | Sell |
142,350
-4,870
| -3% | -$205K | ﹤0.01% | 2343 |
|
|
2014
Q3 | $5.73M | Buy |
147,220
+23,151
| +19% | +$909K | ﹤0.01% | 2423 |
|
|
2014
Q2 | $5.25M | Buy |
124,069
+10,770
| +10% | +$395K | ﹤0.01% | 2482 |
|
|
2014
Q1 | $4.04M | Sell |
113,299
-6,021
| -5% | -$203K | ﹤0.01% | 2694 |
|
|
2013
Q4 | $3.86M | Buy |
+119,320
| New | +$3.54M | ﹤0.01% | 2737 |
|
Northern Trust's ISEE Position: Q3 2023 in Review
Northern Trust sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,327,363 shares — an estimated $52.2M sold.
Northern Trust first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $52.2M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Northern Trust reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Northern Trust sold 1,327,363 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $52.2M.
- Northern Trust first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 39 quarters.
- Northern Trust's IVERIC bio, Inc. Common Stock position peaked at $52.2M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.